Clinical review highlights treatment options and uncertain prognosis in patients with gorham-stout disease.
Gorham-Stout disease (GSD) is a rare disorder of unknown etiology, characterized by progressive osteolysis due to abnormal proliferation of lymphatic and vascular tissue within the bone. It can affect the entire skeleton. Symptoms may include bone pain, swelling, and fractures. Diagnosis relies mainly on imaging and histology. Treatment may include bisphosphonates (osteoclast inhibitors), sirolimus (mTOR (mechanistic Target Of Rapamycin) inhibitor), radiotherapy, and surgery. The prognosis is uncertain and depending on the location and severity of the lesions, the condition may be life-threatening. This article reviews the current knowledge about this disease and illustrates it with a clinical case.
No takes yet. Share an insight, caveat, or question.
Brügger et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: